Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia

Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 31; no. 19; pp. e300 - e303
Main Authors: Dietrich, Sascha, Hüllein, Jennifer, Hundemer, Michael, Lehners, Nicola, Jethwa, Alexander, Capper, David, Acker, Till, Garvalov, Boyan K, Andrulis, Mindaugas, Blume, Carolin, Schulte, Christoph, Mandel, Thomas, Meissner, Julia, Fröhling, Stefan, von Kalle, Christof, Glimm, Hanno, Ho, Anthony D, Zenz, Thorsten
Format: Journal Article
Language:English
Published: United States 01-07-2013
Subjects:
Antibodies, Monoclonal, Murine-Derived - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - pharmacology
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cladribine - administration & dosage
Drug Resistance, Neoplasm
Flow Cytometry
Glutamic Acid
Humans
Indoles - administration & dosage
Indoles - adverse effects
Indoles - pharmacology
Indoles - therapeutic use
Induction Chemotherapy
Leukemia, Hairy Cell - diagnosis
Leukemia, Hairy Cell - drug therapy
Leukemia, Hairy Cell - genetics
Male
Middle Aged
Molecular Targeted Therapy
Point Mutation
Proto-Oncogene Proteins B-raf - antagonists & inhibitors
Proto-Oncogene Proteins B-raf - genetics
Rituximab
Sulfonamides - administration & dosage
Sulfonamides - adverse effects
Sulfonamides - pharmacology
Sulfonamides - therapeutic use
Treatment Outcome
Valine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2012.45.9495